Overview

Bioequivalence Study of Ivermectin 1% Cream and Soolantra (Ivermectin) 10 mg/g Cream

Status:
COMPLETED
Trial end date:
2024-07-22
Target enrollment:
Participant gender:
Summary
Single dose bioequivalence study of Ivermectin 1% cream and Soolantra (Ivermectin) 10 mg/g cream in healthy adult human subjects.
Phase:
PHASE1
Details
Lead Sponsor:
Humanis Saglık Anonim Sirketi
Treatments:
Ivermectin